TYRLIQTO Trademark

Trademark Overview

On Thursday, March 18, 2021, a trademark application was filed for TYRLIQTO with the United States Patent and Trademark Office. The USPTO has given the TYRLIQTO trademark a serial number of 90587313. The federal status of this trademark filing is FIFTH EXTENSION - GRANTED as of Friday, May 31, 2024. This trademark is owned by Boehringer Ingelheim International GmbH. The TYRLIQTO trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations, namely, pharmaceutical preparations for the treatment of diseases and disorders of the alimentary tract and metabolism, and blood and blood forming organs; pharmaceutical preparations for the treatment of diseases and disorders of the cardiovascular system, musculoskeletal system, central nervous system, peripheral nervous system, genitourinary system and respiratory system; and pharmaceutical preparations for the treatment of dermatological, hormonal, infectious, viral and oncological diseases and disorders
tyrliqto

General Information

Serial Number90587313
Word MarkTYRLIQTO
Filing DateThursday, March 18, 2021
Status734 - FIFTH EXTENSION - GRANTED
Status DateFriday, May 31, 2024
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, November 2, 2021

Trademark Statements

Goods and ServicesPharmaceutical preparations, namely, pharmaceutical preparations for the treatment of diseases and disorders of the alimentary tract and metabolism, and blood and blood forming organs; pharmaceutical preparations for the treatment of diseases and disorders of the cardiovascular system, musculoskeletal system, central nervous system, peripheral nervous system, genitourinary system and respiratory system; and pharmaceutical preparations for the treatment of dermatological, hormonal, infectious, viral and oncological diseases and disorders

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateTuesday, June 22, 2021
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameBoehringer Ingelheim International GmbH
Party Type20 - Owner at Publication
Legal Entity Type99 - Other
AddressIngelheim 55218
DE
Party NameBoehringer Ingelheim International GmbH
Party Type10 - Original Applicant
Legal Entity Type99 - Other
AddressIngelheim 55218
DE

Trademark Events

Event DateEvent Description
Monday, March 22, 2021NEW APPLICATION ENTERED
Tuesday, June 22, 2021NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Thursday, September 16, 2021ASSIGNED TO EXAMINER
Thursday, September 23, 2021APPROVED FOR PUB - PRINCIPAL REGISTER
Monday, October 11, 2021TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Monday, October 11, 2021ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Monday, October 11, 2021TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS
Monday, October 11, 2021TEAS CHANGE OF CORRESPONDENCE RECEIVED
Wednesday, October 13, 2021NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, November 2, 2021PUBLISHED FOR OPPOSITION
Tuesday, November 2, 2021OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, December 28, 2021NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, January 11, 2022TEAS PETITION TO AMEND BASIS RECEIVED
Monday, January 24, 2022ASSIGNED TO EXAMINER
Wednesday, January 26, 2022ASSIGNED TO PETITION STAFF
Monday, January 31, 2022PETITION INQUIRY LETTER ISSUED
Friday, February 25, 2022TEAS RESPONSE TO PETITION INQUIRY LETTER
Tuesday, March 1, 2022PETITION TO DIRECTOR - MAKE SPECIAL - GRANTED
Tuesday, March 1, 2022ATTORNEY REVIEW/DECISION ON AMENDMENT REQUIRED
Wednesday, June 1, 2022SOU TEAS EXTENSION RECEIVED
Wednesday, June 1, 2022SOU EXTENSION 1 FILED
Wednesday, June 1, 2022SOU EXTENSION 1 GRANTED
Friday, June 3, 2022NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, July 7, 2022ASSIGNED TO EXAMINER
Tuesday, December 6, 2022SOU TEAS EXTENSION RECEIVED
Tuesday, December 6, 2022SOU EXTENSION 2 FILED
Tuesday, December 6, 2022SOU EXTENSION 2 GRANTED
Thursday, December 8, 2022NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, May 31, 2023SOU TEAS EXTENSION RECEIVED
Wednesday, May 31, 2023SOU EXTENSION 3 FILED
Wednesday, May 31, 2023SOU EXTENSION 3 GRANTED
Friday, June 2, 2023NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, December 5, 2023SOU TEAS EXTENSION RECEIVED
Tuesday, December 5, 2023SOU EXTENSION 4 FILED
Tuesday, December 5, 2023SOU EXTENSION 4 GRANTED
Thursday, December 7, 2023NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Friday, May 31, 2024SOU TEAS EXTENSION RECEIVED
Friday, May 31, 2024SOU EXTENSION 5 FILED
Friday, May 31, 2024SOU EXTENSION 5 GRANTED
Thursday, June 13, 2024NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED

Related Keywords

tyrliqto system pharmaceutical preparations diseases disorders treatment blood nervous peripheral genitourinary